Friday, August 13, 2010
Oncologists Issue New Guidelines Regarding Hormonal Therapy
The ASCO recently announced that adding an aromatase inhibitor during breast cancer treatment results in a lower risk of recurrence.
skip to main |
skip to sidebar
An RSS feed for the weekly update of relevant headlines from TheBreastCareSite.com